This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sands, R. P. Articles by Lema, M. J. Search for Related Content PubMed Articles by Sands, R. P., JR Articles by Lema, M. J. Social Bookmarking                   What's this?

Postthoracotomy Syndrome and Postherpetic Neuralgia

Roswell Park Cancer Institute, Buffalo, NY

Anthony T. Yarussi

Roswell Park Cancer Institute, Buffalo, NY

Mark J. Lema

Roswell Park Cancer Institute, Buffalo, NY

Postthoractomy syndrome (PTS) is a multifactorial dis ease process which has never been adequately de scribed. This, in turn, has led to a discrepancy in the literature concerning the signs and symptoms which constitute PTS and what are the most efficacious treat ment modalities that should be used. The most impor tant fact before instituting therapy for PTS, is that recurrent disease must be ruled out. Once this is done, a stepped-treatment regimen can be instituted. Postherpetic neuralgia (PHN) is a disease state which afflicts 10% to 15% of patients who become infected with herpes zoster. At this time, there appears to be no definitive treatment regimen for PHN. However, there are various treatment modalities which can signifi cantly decrease the pain associated with the disease. There seem to be many promising agents undergoing scientific trials, so that a definitive treatment for PHN may soon be available.

Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 3, No. 3, 168-176 (1999)
DOI: 10.1177/108925329900300304


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?